Pentam 300 Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pentam 300 (NDC 63323-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pentam-structure (Pentam 300 Figure 1 Pentam Structure)

FDA Label Image
Logo (Pentam 300 Figure 2 Add Band Logo)
APP Pharmaceuticals, LLC is a pharmaceutical company located in Schaumburg, IL 60173.*
FDA Label Image

11310-vial (Pentam 300 Figure 3 11310 Vial)

11310-vial (Pentam 300 Figure 3 11310 Vial)
This is a description of Pentamidine Isethionate, an injectable medication that must be reconstituted with sterile water or 5% dextrose injection. The medication is stored in a dry form at room temperature and must be protected from light. The package insert should be consulted for appropriate dosage information. The medication is produced by APP Pharmaceuticals, LLC and the details of the lot/exp are not readable.*
FDA Label Image

11310-carton (Pentam 300 Figure 4 11310 Carton)

11310-carton (Pentam 300 Figure 4 11310 Carton)
This text is a product label for PENTAMĀ® 300, a lyophilized medication containing pentamidine isethionate for injection. It comes in a 300mg dosage and is intended for intramuscular or intravenous use. The specific package contains 10 single-dose vials.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.